These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7519415)

  • 1. SSPE and interferon.
    Philippart M
    Brain Dev; 1994; 16(2):168. PubMed ID: 7519415
    [No Abstract]   [Full Text] [Related]  

  • 2. Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex.
    Le Cras R; Mazet R; Dubois-Teklali F; Sabourdy C; Chanoine S; Lehmann A; Morin A; Leenhardt J; Durand M; Desruet MD; Bedouch P
    Emerg Microbes Infect; 2023 Dec; 12(1):2148563. PubMed ID: 36458570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of SSPE by intrathecal infusion of alpha-IFN.
    Kurata T; Matsubara E; Yokoyama M; Nagano I; Shoji M; Abe K
    Neurology; 2004 Jul; 63(2):398-9. PubMed ID: 15277654
    [No Abstract]   [Full Text] [Related]  

  • 4. Subacute sclerosing panencephalitis.
    Gascon GG; Crowell J; Stigsby B; Yamani S
    Neurology; 1993 Feb; 43(2):454-5. PubMed ID: 7679784
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE).
    Streletz LJ; Cracco J
    Ann Neurol; 1977 Feb; 1(2):183-4. PubMed ID: 70187
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary results for treatments in subacute sclerosing panencephalitis have problems?
    Anlar B
    J Child Neurol; 2004 Jun; 19(6):463; author reply 463-4. PubMed ID: 15446398
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].
    Nihei K; Kudo H; Abe T; Naito H; Suzuki S; Miyao M
    No To Hattatsu; 1984 Jul; 16(4):262-70. PubMed ID: 6207848
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.
    Gascon G; Yamani S; Crowell J; Stigsby B; Nester M; Kanaan I; Jallu A
    Brain Dev; 1993; 15(5):346-55. PubMed ID: 7506498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of inosiplex on the survival of subacute sclerosing panencephalitis.
    DuRant RH; Dyken PR
    Neurology; 1983 Aug; 33(8):1053-5. PubMed ID: 6192362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprinosine in SSPE.
    Addy DP
    Neurology; 1980 Nov; 30(11):1255-6. PubMed ID: 6158715
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of CSF serology in follow-up of subacute sclerosing panencephalitis patients on treatment.
    Gupta E; Dar L; Singh S; Behari M; Broor S
    Indian J Med Microbiol; 2006 Apr; 24(2):131-2. PubMed ID: 16687866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoprinosine therapy and SSPE.
    Huttenlocker PR
    Ann Neurol; 1980 Dec; 8(6):642. PubMed ID: 6163393
    [No Abstract]   [Full Text] [Related]  

  • 13. Inosiplex for SSPE.
    Jones C
    Lancet; 1982 Aug; 2(8296):495. PubMed ID: 6180266
    [No Abstract]   [Full Text] [Related]  

  • 14. Inosiplex for SSPE.
    Chalmers TC; Smith H
    Lancet; 1982 Jun; 1(8287):1475. PubMed ID: 6177984
    [No Abstract]   [Full Text] [Related]  

  • 15. SSPE incidence, therapy receive renewed attention.
    Gunby P
    JAMA; 1981 Aug; 246(9):927, 931-2. PubMed ID: 6166765
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine].
    Filipowicz A; GrudziƄska B
    Neurol Neurochir Pol; 1987; 21(4-5):352-6. PubMed ID: 2451185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis.
    Mehta PD; Kulczycki J; Patrick BA; Sobczyk W; Wisniewski HM
    J Neurol Sci; 1992 May; 109(1):64-8. PubMed ID: 1381411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isoprinosine therapy of subacute sclerosing panencephalitis].
    Goetz O
    Monatsschr Kinderheilkd; 1981 Nov; 129(11):655-7. PubMed ID: 6172706
    [No Abstract]   [Full Text] [Related]  

  • 19. SSPE treated with isoprinosine: immunopathological observations.
    Streletz LJ; Sethi BS; Graziani LJ; Duckett SW
    Ann Neurol; 1985 Jan; 17(1):105-6. PubMed ID: 2580477
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of isoprinosine in subacute sclerosing panencephalitis.
    McGrath E; Rosenbloom L
    Arch Dis Child; 1980 Oct; 55(10):829-30. PubMed ID: 6159826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.